Growth factors in haematology: Prophylactic versus interventional use

This publication has 13 references indexed in Scilit:

• Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial
  The Lancet, 1993
• A controlled trial of recombinant human granulocyte-macrophage colony- stimulating factor after total body irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for acute lymphoblastic leukemia or malignant lymphoma
  Blood, 1992
• Phase II trial of recombinant human granulocyte-macrophage colony- stimulating factor in patients undergoing allogeneic bone marrow transplantation from unrelated donors
  Blood, 1992
• In vivo administration of granulocyte‐macrophage colony stimulating factor enhances neutrophil function in patients with myelodysplastic syndromes
  British Journal of Haematology, 1991
• Treatment with granulocyte‐macrophage colony stimulating factor and the adult respiratory distress syndrome
  American Journal of Hematology, 1991
• Effect of Granulocyte Colony-Stimulating Factor after Intensive Induction Therapy in Relapsed or Refractory Acute Leukemia
  New England Journal of Medicine, 1990
• Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia
  Blood, 1990
• Effect of Treatment with rhGM-CSF and Low-Dose Cytosine Arabinoside on Leukemic Blast Cells in Patients with Myelodysplastic Syndromes
  Published by Springer Nature ,1990
• Progress in the therapy of myelodysplastic syndromes
  Annals of Hematology, 1989
• Treatment of refractory aplastic anemia with recombinant human granulocyte-macrophage-colony-stimulating factor
  Blood, 1989